Lawsuits Filed Against PINS, GDRX and OTGLY - Jakubowitz Law Pursues Shareholders Claims

NEW YORK, NY / ACCESSWIRE / January 21, 2021 /Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who purchased shares within the class periods listed below. Shareholders interested in representing the class of wronged shareholders have until the lead plaintiff deadline to petition the court. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. For more details and to speak with our firm without cost or obligation, follow the links below.

Pinterest, Inc. (NYSE:PINS)

CONTACT JAKUBOWITZ ABOUT PINS:
https://claimyourloss.com/securities/pinterest-inc-loss-submission-form/?id=12328&from=1

Class Period : May 16, 2019 - November 1, 2019

Lead Plaintiff Deadline: January 22, 2021

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) the Company's addressable market in the U.S. was reaching its maximum capacity; (ii) which significantly decelerated Pinterest's future ability to monetize on U.S. average revenue per user; (iii) Pinterest was at an increased risk of losing advertising revenue; (iv) and as a result, Defendants' public statements were materially false and misleading at all relevant times or lacked a reasonable basis and omitted material facts.

GoodRx Holdings, Inc (NASDAQ:GDRX)

CONTACT JAKUBOWITZ ABOUT GDRX:
https://claimyourloss.com/securities/goodrx-holdings-inc-loss-submission-form/?id=12328&from=1

Class Period : September 23, 2020 - November 16, 2020

Lead Plaintiff Deadline: February 16, 2021

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: at the time of the IPO, unbeknownst to investors, Amazon.com, Inc. was developing and would soon introduce its own online and mobile prescription medication ordering and fulfillment service that would directly compete with GoodRx. Defendants timed the IPO so that it was priced before Amazon announced its online pharmaceutical business to facilitate the IPO and create artificial demand for the common shares sold therein, as well to maximize the amount of money the Company and the selling stockholders could raise in the IPO. Given defendants' knowledge of Amazon's intention to enter the online pharmaceutical business, and their misleading statements about GoodRx's competitive position made contemporaneously with that knowledge, defendants' materially false and/or misleading statements alleged herein were made willfully and caused GoodRx common stock to trade at artificially inflated prices during the Class Period.

CD Projekt S.A. (OTCMKT:OTGLY)

CONTACT JAKUBOWITZ ABOUT OTGLY:
https://claimyourloss.com/securities/cd-projekt-s-a-loss-submission-form/?id=12328&from=1

Class Period : January 16, 2020 - December 17, 2020

Lead Plaintiff Deadline: February 22, 2021

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: Throughout the class period, defendants were materially false and/or misleading because they misrepresented and failed to disclose the following adverse facts pertaining to the Company's business, operations and prospects, which were known to Defendants or recklessly disregarded by them. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (1) Cyberpunk 2077 was virtually unplayable on the current-generation Xbox or Playstation systems due to an enormous number of bugs; (2) as a result, Sony would remove Cyberpunk 2077 from the Playstation store, and Sony, Microsoft and the Company would be forced to offer full refunds for the game; (3) consequently, the Company would suffer reputational and pecuniary harm; and (4) as a result, Defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Jakubowitz Law is vigorous in pursuit of justice for shareholders who have been the victim of securities fraud. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

JAKUBOWITZ LAW
1140 Avenue of the Americas
9th Floor
New York, New York 10036
T: (212) 867-4490
F: (212) 537-5887

SOURCE:Jakubowitz Law

View source version on accesswire.com:
https://www.accesswire.com/625327/Lawsuits-Filed-Against-PINS-GDRX-and-OTGLY--Jakubowitz-Law-Pursues-Shareholders-Claims

© 2021 Accesswire. All Rights Reserved.